Well, there could be 2 schools of thought on this quote.
"We do not know yet if the normal RECAF concentration is constant enough to make this personalization possible."
I was focusing on "do not know yet", possibly meaning it has to be proven either way, through extensive samples and testing, in order to posssibly be included in with a future FDA submission, which could take time.
If you had put my quote that you pasted into context, you'd see that I didn't deny that there would be variations, only I believe that in the end, for most, the variations will probably be insignificant for the purposes of early cancer detection.
Erthang
